Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor
Loredana Vesci, Elena Bernasconi, Ferdinando Maria Milazzo, et al.
Oncotarget (2014) Vol. 6, Iss. 8, pp. 5735-5748
Open Access | Times Cited: 16

Showing 16 citing articles:

Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors—What Some May Have Forgotten or Would Rather Forget?
Sida Shen, Alan P. Kozikowski
ChemMedChem (2015) Vol. 11, Iss. 1, pp. 15-21
Open Access | Times Cited: 219
Zinc binding groups for histone deacetylase inhibitors
Lei Zhang, Jian Zhang, Qixiao Jiang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2018) Vol. 33, Iss. 1, pp. 714-721
Open Access | Times Cited: 195
The Search for Potent, Small‐Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
Chiara Zagni, Giuseppe Floresta, Giulia Monciino, et al.
Medicinal Research Reviews (2017) Vol. 37, Iss. 6, pp. 1373-1428
Closed Access | Times Cited: 117
Zinc-dependent Deacetylase (HDAC) Inhibitors with Different Zinc Binding Groups
Yan Li, Fang Wang, Xiaoxue Chen, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 3, pp. 223-241
Closed Access | Times Cited: 60
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features
Alberto J. Arribas, Andrea Rinaldi, Afua A. Mensah, et al.
Blood (2015) Vol. 125, Iss. 12, pp. 1922-1931
Open Access | Times Cited: 61
Histone deacetylase inhibitor based prodrugs
Wenli Fan, Lihui Zhang, Qixao Jiang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 203, pp. 112628-112628
Closed Access | Times Cited: 36
Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response
Afua A. Mensah, Ivo Kwee, Eugenio Gaudio, et al.
Oncotarget (2014) Vol. 6, Iss. 7, pp. 5059-5071
Open Access | Times Cited: 32
Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation
Elena Cini, Valentina Faltoni, Elena Petricci, et al.
Chemical Science (2018) Vol. 9, Iss. 31, pp. 6490-6496
Open Access | Times Cited: 26
2,5-Dimethyl-Celecoxib Inhibits Cell Cycle Progression and Induces Apoptosis in Human Leukemia Cells
Cyril Sobolewski, Jiyun Rhim, Noémie Legrand, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 355, Iss. 2, pp. 308-328
Open Access | Times Cited: 22
The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent
Roger Badía, Judith Grau-Expósito, Eva Riveira‐Muñoz, et al.
Antiviral Research (2015) Vol. 123, pp. 62-69
Closed Access | Times Cited: 17
ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1
Ferdinando Maria Milazzo, Loredana Vesci, Anna Maria Anastasi, et al.
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 15
Antibody drug conjugates beyond cytotoxic payloads
Adrian D. Hobson
Progress in medicinal chemistry (2023), pp. 1-59
Closed Access | Times Cited: 5
Targeting Cancer with Epi-Drugs: A Precision Medicine Perspective
Lisa Gherardini, Ankush Sharma, Enrico Capobianco, et al.
Current Pharmaceutical Biotechnology (2016) Vol. 17, Iss. 10, pp. 856-865
Closed Access | Times Cited: 12
A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides
Elena Ermini, Annalaura Brai, Elena Cini, et al.
Chemical Science (2024) Vol. 15, Iss. 16, pp. 6168-6177
Open Access | Times Cited: 1
Synthesis of ST7612AA1, a Novel Oral HDAC Inhibitor, via Radical Thioacetic Acid Addition
Gianfranco Battistuzzi, Giuseppe Giannini
Current Bioactive Compounds (2016) Vol. 12, Iss. 4, pp. 282-288
Open Access | Times Cited: 6
Targeting (de)acetylation: A Diversity of Mechanism and Disease
Colleen E. Quaas, David T. Long
Elsevier eBooks (2021), pp. 469-492
Closed Access
Page 1

Scroll to top